These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33449100)

  • 1. CRISPR base editing applications for identifying cancer-driving mutations.
    Pal M; Herold MJ
    Biochem Soc Trans; 2021 Feb; 49(1):269-280. PubMed ID: 33449100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR Diagnosis and Therapeutics with Single Base Pair Precision.
    Lee SH; Park YH; Jin YB; Kim SU; Hur JK
    Trends Mol Med; 2020 Mar; 26(3):337-350. PubMed ID: 31791730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can genetic engineering-based methods for gene function identification be eclipsed by genome editing in plants? A comparison of methodologies.
    Amritha PP; Shah JM
    Mol Genet Genomics; 2021 May; 296(3):485-500. PubMed ID: 33751237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-dCas9 Mediated Cytosine Deaminase Base Editing in
    Yu S; Price MA; Wang Y; Liu Y; Guo Y; Ni X; Rosser SJ; Bi C; Wang M
    ACS Synth Biol; 2020 Jul; 9(7):1781-1789. PubMed ID: 32551562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas9 therapies in experimental mouse models of cancer.
    Estêvão D; Rios Costa N; da Costa RG; Medeiros R
    Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
    Shen J; Zhou J; Chen GQ; Xiu ZL
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
    [No Abstract]   [Full Text] [Related]  

  • 10. Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review).
    Alagoz M; Kherad N
    Int J Mol Med; 2020 Aug; 46(2):521-534. PubMed ID: 32467995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Powerful Microbial Base-Editing Toolbox: From Optimization Strategies to Versatile Applications.
    Li K; Qin LY; Zhang ZX; Yan CX; Gu Y; Sun XM; Huang H
    ACS Synth Biol; 2023 Jun; 12(6):1586-1598. PubMed ID: 37224027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new era of gene editing for the treatment of human diseases.
    Kc M; Steer CJ
    Swiss Med Wkly; 2019 Jan; 149():w20021. PubMed ID: 30685869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
    Liu W; Yang C; Liu Y; Jiang G
    Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient CRISPR-mediated base editing in
    Rodrigues SD; Karimi M; Impens L; Van Lerberge E; Coussens G; Aesaert S; Rombaut D; Holtappels D; Ibrahim HMM; Van Montagu M; Wagemans J; Jacobs TB; De Coninck B; Pauwels L
    Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33443212
    [No Abstract]   [Full Text] [Related]  

  • 16. Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy.
    Potts MA; McDonald JA; Sutherland KD; Herold MJ
    Eur J Immunol; 2020 Dec; 50(12):1871-1884. PubMed ID: 33202035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of CRISPR systems in respiratory health: Entering a new 'red pen' era in genome editing.
    Moses C; Kaur P
    Respirology; 2019 Jul; 24(7):628-637. PubMed ID: 30883991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Base Editing Systems Are Available for Plants.
    Marzec M; Hensel G
    Trends Plant Sci; 2018 Nov; 23(11):955-957. PubMed ID: 30224156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
    J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the application of CRISPR: From gene to base editing.
    Wu W; Yang Y; Lei H
    Med Res Rev; 2019 Mar; 39(2):665-683. PubMed ID: 30171624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.